(CercleFinance.com) – Quantum Genomics announces the refoundation of its Scientific and Clinical Committee with the appointment of new members, an operation supposed to reflect “the state of maturity of the company”, assures the laboratory.
Thus, Professor George L. Bakris, from Chicago, (nephrologist specializing in resistant and refractory hypertension), Professor Gregory Y. H Lip, from Liverpool, UK, (world-renowned clinical expert) and Professor Atul Pathak ( Head of the Cardiology Department of the Princess Grace Hospital in Monaco) joined the committee.
They will find there Professor Keith C. Ferdinand (Cardiologist and specialist in arterial hypertension) and Professor Alexandre Persu (Head of Clinic in Cardiology).
‘While Firibastat is now close to being put on the market, we must rely on clinical experts close to practices and involved in scientific recommendations and learned societies’, essentially indicates Lionel Ségard, president of Quantum Genomics.
As a reminder, the Scientific and Clinical Committee advises Quantum Genomics on its clinical development plan and its strategies and recommendations on future developments.